CYP2C19 and ABCB1 Genetic Polymorphisms Correlate With the Recurrence of Ischemic Cardiovascular Adverse Events After Clopidogrel Treatment
Journal of Clinical Laboratory Analysis - United States
doi 10.1002/jcla.22369
Full Text
Open PDFAbstract
Available in full text
Categories
Date
February 4, 2018
Authors
Publisher
Wiley